| Heart disease and stroke statistics—2016 update: a report from the American Heart Association D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ... circulation 133 (4), e38-e360, 2016 | 68008* | 2016 |
| Dapagliflozin in patients with heart failure and reduced ejection fraction JJV McMurray, SD Solomon, SE Inzucchi, L Køber, MN Kosiborod, ... New England Journal of Medicine 381 (21), 1995-2008, 2019 | 5621 | 2019 |
| Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 121-130, 2019 | 2228 | 2019 |
| Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American … JS Skyler, R Bergenstal, RO Bonow, J Buse, P Deedwania, EAM Gale, ... Circulation 119 (2), 351-357, 2009 | 1986 | 2009 |
| Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline GE Umpierrez, R Hellman, MT Korytkowski, M Kosiborod, GA Maynard, ... The Journal of Clinical Endocrinology & Metabolism 97 (1), 16-38, 2012 | 1351 | 2012 |
| Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial AF Hernandez, JB Green, S Janmohamed, RB D'Agostino, CB Granger, ... The Lancet 392 (10157), 1519-1529, 2018 | 1329 | 2018 |
| Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction SD Solomon, JJV McMurray, B Claggett, RA de Boer, D DeMets, ... New England Journal of Medicine 387 (12), 1089-1098, 2022 | 1190 | 2022 |
| Excess mortality among persons with type 2 diabetes M Tancredi, A Rosengren, AM Svensson, M Kosiborod, A Pivodic, ... New England Journal of Medicine 373 (18), 1720-1732, 2015 | 1117 | 2015 |
| The obesity paradox: body mass index and outcomes in patients with heart failure JP Curtis, JG Selter, Y Wang, SS Rathore, IS Jovin, F Jadbabaie, ... Archives of internal medicine 165 (1), 55-61, 2005 | 998 | 2005 |
| Glycemic control and excess mortality in type 1 diabetes M Lind, AM Svensson, M Kosiborod, S Gudbjörnsdottir, A Pivodic, ... New England Journal of Medicine 371 (21), 1972-1982, 2014 | 963 | 2014 |
| Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association … CS Fox, SH Golden, C Anderson, GA Bray, LE Burke, IH De Boer, ... Circulation 132 (8), 691-718, 2015 | 954 | 2015 |
| Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes M Kosiborod, SS Rathore, SE Inzucchi, FA Masoudi, Y Wang, ... Circulation 111 (23), 3078-3086, 2005 | 899 | 2005 |
| Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk M Kosiborod, SE Inzucchi, HM Krumholz, L Xiao, PG Jones, S Fiske, ... Circulation 117 (8), 1018-1027, 2008 | 864* | 2008 |
| Sotagliflozin in patients with diabetes and chronic kidney disease DL Bhatt, M Szarek, B Pitt, CP Cannon, LA Leiter, DK McGuire, JB Lewis, ... New England Journal of Medicine 384 (2), 129-139, 2021 | 848 | 2021 |
| Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006 H Bueno, JS Ross, Y Wang, J Chen, MT Vidán, SLT Normand, JP Curtis, ... Jama 303 (21), 2141-2147, 2010 | 832 | 2010 |
| Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and … P Deedwania, M Kosiborod, E Barrett, A Ceriello, W Isley, T Mazzone, ... Circulation 117 (12), 1610-1619, 2008 | 832* | 2008 |
| 13. Children and Adolescents: Standards of Medical Care in Diabetes—2021 American Diabetes Association Diabetes care 44 (Supplement_1), S180-S199, 2021 | 825* | 2021 |
| Lower risk of heart failure and death in patients initiated on sodium-glucose cotransporter-2 inhibitors versus other glucose-lowering drugs: the CVD-REAL study (comparative … M Kosiborod, MA Cavender, AZ Fu, JP Wilding, K Khunti, RW Holl, ... Circulation 136 (3), 249-259, 2017 | 728 | 2017 |
| Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry TT Tsai, UD Patel, TI Chang, KF Kennedy, FA Masoudi, ME Matheny, ... JACC: Cardiovascular Interventions 7 (1), 1-9, 2014 | 625 | 2014 |
| Type 2 diabetes mellitus and heart failure: a scientific statement from the American Heart Association and the Heart Failure Society of America: this statement does not … SM Dunlay, MM Givertz, D Aguilar, LA Allen, M Chan, AS Desai, A Deswal, ... Circulation 140 (7), e294-e324, 2019 | 539 | 2019 |
